PulseAugur
EN
LIVE 21:03:30
中文(ZH) 总部位于美国的生物技术公司Axiom正寻求在香港上市

Axiom eyes Hong Kong IPO; 3M raises guidance; OpenAI halts GPT-6

Axiom, a US-based biotechnology company, is reportedly exploring a listing in Hong Kong. Separately, 3M announced its Q2 2026 financial results, showing a 2.4% increase in GAAP sales to $6.5 billion and raising its full-year earnings guidance. In AI news, WAIC 2026 has identified 15 core trends for the latter half of the AI industry, while OpenAI has reportedly halted the development of GPT-6. AI

IMPACT OpenAI's reported halt on GPT-6 development suggests a potential shift in AI research priorities or challenges.

RANK_REASON The cluster contains a mix of company financial news, AI industry trends, and a speculative AI model development halt, none of which rise to the level of a frontier release or significant industry event.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Axiom eyes Hong Kong IPO; 3M raises guidance; OpenAI halts GPT-6

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    US-based biotechnology company Axiom seeks Hong Kong listing

    总部位于美国的生物技术公司Axiom正寻求在香港上市。(财联社)